Is It Possible to Develop Cancer Vaccines to Neoantigens, What Are the Major Challenges, and How Can These Be Overcome? Neoantigens: Nothing New in Spite of the Name

Finn, Olivera J.; Rammensee, Hans-Georg

dc.contributor.author	Rammensee, Hans-Georg
dc.date.accessioned	2019-08-16T08:07:19Z
dc.date.available	2019-08-16T08:07:19Z
dc.date.issued	2018
dc.identifier.issn	1943-0264
dc.identifier.uri	http://hdl.handle.net/10900/91562
dc.language.iso	en	en
dc.publisher	Cold Spring Harbor Lab Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1101/cshperspect.a028829
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Is It Possible to Develop Cancer Vaccines to Neoantigens, What Are the Major Challenges, and How Can These Be Overcome? Neoantigens: Nothing New in Spite of the Name	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_00620
utue.personen.roh	Finn, Olivera J.
utue.personen.roh	Rammensee, Hans-Georg
dcterms.isPartOf.ZSTitelID	Cold Spring Harbor Perspectives in Biology	de_DE
dcterms.isPartOf.ZS-Issue	Article a028829	de_DE
dcterms.isPartOf.ZS-Volume	10	de_DE
utue.fakultaet	04 Medizinische Fakultät
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät
utue.fakultaet	Sonstige